核医学与精准医疗的融合，正催生一场癌症治疗的颠覆性变革。 放射性配体疗法（Radioligand Therapy，RLT），一种被誉为“生物导弹”的癌症新疗法，已在前列腺癌治疗领域显示出显著的潜力，并在全球医疗界引起广泛关注。它通过将放射性核素精准递送至肿瘤细胞，实现“定向核打击”，在杀死癌细胞的同时，对健康组织损伤降至最低。 近来，围绕这一疗法的新消息也是不断出现。近日，诺华宣布其放射配体...
Source Link核医学与精准医疗的融合，正催生一场癌症治疗的颠覆性变革。 放射性配体疗法（Radioligand Therapy，RLT），一种被誉为“生物导弹”的癌症新疗法，已在前列腺癌治疗领域显示出显著的潜力，并在全球医疗界引起广泛关注。它通过将放射性核素精准递送至肿瘤细胞，实现“定向核打击”，在杀死癌细胞的同时，对健康组织损伤降至最低。 近来，围绕这一疗法的新消息也是不断出现。近日，诺华宣布其放射配体...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.